S. Sailaja
S. Sailaja publishes mostly in Organic Chemistry, Molecular Biology and Inorganic Chemistry, on topics such as Synthesis and Reactions of Organic Compounds, Synthesis and Biological Evaluation and Synthesis and biological activity.
- World rank
- #6,323,370 of 7,710,434 ranked researchers
- Rank in India
- #203,486 of 280,097
- Works
- 43
- Citations
- 204
- Citations per work
- 4.7
What does S. Sailaja research?
S. Sailaja's work is mostly in Chemistry (64%), Medicine (10%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2864.0%
- Chemistry2864.0%
- Everything else819.3%
- Health Sciences49.8%
- Medicine49.8%
- Life Sciences36.9%
- 1Organic Chemistry56% of their works
- 2Molecular Biology7% of their works
- 3Inorganic Chemistry6% of their works
- 4Oncology6% of their works
- 5Infectious Diseases4% of their works
- 6Physical and Theoretical Chemistry3% of their works
Research topics
- Synthesis and Reactions of Organic Compounds
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Phenothiazines and Benzothiazines Synthesis and Activities
- Quinazolinone synthesis and applications
- Metal complexes synthesis and properties
- Metal-Organic Frameworks: Synthesis and Applications
Which keywords describe S. Sailaja's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Anticancer Agents, Anticancer, Antimicrobial, Catalyst, Heterocycles and Heterocyclic Compounds.
- Metal-Organic Frameworks
- Cisplatin Resistance
- Indirubin
- Biological Activities
- Tubulin Inhibitors
- Drug Discovery
- Oxazolones
- Antimicrobial Activity
- Heterocyclic Compounds
- Catalyst
- Anticancer
- Biological Evaluation
- Synthesis
- Anticancer Agents
- Antimicrobial
- Heterocycles
- Medicinal Chemistry
- Imidazoles
- Quinoxaline
- Triazines
- Vascular Targeting Agents
- Phenothiazines
- Quinazoline
- Platinum-Based Drugs
- Porous Materials
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Synthesis295 topics
- Biological Evaluation173 topics
- Anticancer Agents163 topics
- Anticancer153 topics
- Antimicrobial153 topics
- Catalyst142 topics
- Heterocycles132 topics
- Heterocyclic Compounds132 topics
- Medicinal Chemistry132 topics
- Antimicrobial Activity71 topic
- Imidazoles71 topic
- Oxazolones71 topic
- Quinoxaline71 topic
- Drug Discovery61 topic
- Triazines61 topic
- Tubulin Inhibitors61 topic
- Vascular Targeting Agents61 topic
- Biological Activities51 topic
- Phenothiazines51 topic
- Indirubin41 topic
- Quinazoline41 topic
- Cisplatin Resistance31 topic
- Platinum-Based Drugs31 topic
- Metal-Organic Frameworks21 topic
- Porous Materials21 topic
Where does S. Sailaja work?
S. Sailaja's main affiliation in the publication record is Dr. Reddy's Laboratories (India), India.
How many publications and citations does S. Sailaja have?
OpenAlex counts 43 works and 204 citations for S. Sailaja, an h-index of 5, ranking #6,323,370 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named S. Sailaja
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about S. Sailaja. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.